A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
Clinical trial NCT05550532 · COMPLETED
Trial details
- NCT number
- NCT05550532
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-06
- Primary completion
- 2024-11-08
- Enrollment
- 444
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.